[Construction and activities of suilysin mutants]

Zhi-qiang Ren1, Yu-ling Zheng, Shu-zhen Gan

  • 1College of Life Science, Sichuan Normal University, Chengdu, China. renzhiq@qq.com

Summary

Researchers created a non-hemolytic suilysin mutant, SLY(P353V), which retains its immunogenicity. This suilysin variant offers potential for applications where hemolytic activity is undesirable but immune response is needed.